Gaby Smeenk

Partner

Office location
Amsterdam, Shanghai
Direct number
+31 20 577 1446
Mobile number
+31 6 53 97 84 22
E-mail
gaby.smeenk@debrauw.com

LinkedIn

Profession
Advocaat, admitted to the Bar in 2003
Partner since
2013
Expertise
Corporate, Mergers & Acquisitions, Capital markets
Languages
Dutch, English
Education
University of Utrecht, University of Sydney

Gaby is a partner in De Brauw’s Corporate practice and has a specific focus on cross-border equity capital markets and M&A transactions.

From 2014 to 2017, Gaby was head of De Brauw’s Shanghai office. Accordingly, Gaby’s more recent work includes acting as lead counsel in transactions with a strong Asian component. She continues working on Asia-related transactions from the Amsterdam office.

Gaby’s recent work includes advising:

  • AkzoNobel on the dual track for its Specialty Chemicals business
  • Unilever on the simplification of its corporate structure
  • Altice on the spin-off of its 67,2% interest in its sister company Altice USA
  • GenScript on its listing on the Hong Kong Stock Exchange
  • ASML on the USD 3 billion acquisition of Hermes Microvision through a public offer
  • NXP on the USD 1.8 billion sale of its amplifiers business to Jianguang Asset Management
  • FrieslandCampina on the entry into a joint venture in China with Huishan Dairy Holdings
  • Rabobank on the divestment of a 90.01% interest in Robeco to Japanese company ORIX Corporation
  • Philips on the divestment of its Lifestyle Entertainment business to Gibson Brands and the sale of its TV business to TPV Technology